![Gary Lee Feiss](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gary Lee Feiss
Profile
Gary Lee Feiss held positions as Director of Clinical Trials at OraSure Technologies, Vice President of Regulatory Affairs at Covalent Group, and VP of Clinical Development & Regulatory Affairs at Saladax Biomedical.
Former positions of Gary Lee Feiss
Companies | Position | End |
---|---|---|
ORASURE TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Covalent Group, Inc. | General Counsel | - |
Saladax Biomedical, Inc.
![]() Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | General Counsel | - |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
ORASURE TECHNOLOGIES, INC. | Health Technology |
Private companies | 2 |
---|---|
Saladax Biomedical, Inc.
![]() Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | Commercial Services |
Covalent Group, Inc. | Commercial Services |
- Stock Market
- Insiders
- Gary Lee Feiss